Extrovis EU is an API manufacturer based in Switzerland. It holds 8 active US drug master files and one valid CEP across a filed portfolio of 8 molecules. Its filings concentrate with US FDA, EMA and FAMHP (BE).
| Site | FDA FEI |
|---|---|
| Baar, Switzerland | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dapsone | EDQM, US FDA | 2 |
| Avibactam | US FDA | 1 |
| Calcium Gluconate | US FDA | 1 |
| Dipotassium Phosphate | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
| Monopotassium Phosphate | US FDA | 1 |
| Tolvaptan | US FDA | 1 |
| Trabectedin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 24 | None |
| EMA | 5 | None |
| FAMHP (BE) | 4 | None |
| AIFA (IT) | 4 | None |
| INFARMED (PT) | 3 | None |
| MPA (SE) | 2 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Extrovis EU, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.